Concepedia
Statistics
Publications
6
Citations
168
H-Index
Active since
2021
Affiliations
Seres Therapeutics (United States)(Current)
University of British Columbia
Gastroenterology Center of Connecticut
Yale University
VA Western New York Healthcare System
Brooke Hasson is an author at Seres Therapeutics (United States).
Publications per year
2021–2023
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent <i>Clostridioides difficile</i> Infection
Matthew Sims, Sahil Khanna, Paul Feuerstadt et al. · JAMA Network Open · 2023 · 74 citations · Full text
Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109
Kevin W. Garey, Jinhee Jo, Anne J Gonzales-Luna et al. · JAMA Network Open · 2023 · 26 citations · Full text
Prevalence of Comorbid Factors in Patients With Recurrent <i>Clostridioides difficile</i> Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota–Based Therapeutic
Charles S. Berenson, Bret A. Lashner, Louis Y. Korman et al. · Clinical Infectious Diseases · 2023 · 20 citations · Full text
Acute carbohydrate overfeeding: a redox model of insulin action and its impact on metabolic dysfunction in humans
Nawfal W. Istfan, Brooke Hasson, Caroline M. Apovian et al. · American Journal of Physiology-Endocrinology and Metabolism · 2021 · 19 citations · Full text
Manufacturing Process of SER-109, a Purified Investigational Microbiome Therapeutic, Reduces Risk of Coronavirus Transmission From Donor Stool
Christopher McChalicher, Ahmad A. Abdul-Aziz, S Steve Zhou et al. · Open Forum Infectious Diseases · 2022 · 18 citations · Full text
1–5 of 6